<SEC-DOCUMENT>0001193125-25-252202.txt : 20251028
<SEC-HEADER>0001193125-25-252202.hdr.sgml : 20251028
<ACCEPTANCE-DATETIME>20251028070009
ACCESSION NUMBER:		0001193125-25-252202
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20251028
DATE AS OF CHANGE:		20251028

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STAAR SURGICAL CO
		CENTRAL INDEX KEY:			0000718937
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				953797439
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1227

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-11634
		FILM NUMBER:		251421239

	BUSINESS ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016
		BUSINESS PHONE:		6263037902

	MAIL ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STAAR SURGICAL COMPANY
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d87705ddefa14a.htm
<DESCRIPTION>DEFA14A EMPLOYEE EMAIL
<TEXT>
<HTML><HEAD>
<TITLE>DEFA14A Employee Email</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROXY
STATEMENT PURSUANT TO SECTION 14(a) OF THE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the Registrant&#8194;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a party other
than the Registrant&#8194;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule</B><B></B><B><FONT
STYLE="white-space:nowrap">&nbsp;14a-6(e)(2))</FONT> </B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material under &#167; <FONT STYLE="white-space:nowrap">240.14a-12</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>STAAR SURGICAL COMPANY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and <FONT
STYLE="white-space:nowrap">0-11.</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>On October&nbsp;27, 2025, the following email was sent to employees of STAAR Surgical Company
(&#8220;STAAR&#8221;): </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Update on Alcon Merger </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To:&nbsp;All Employees of STAAR </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Team, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I&#8217;m writing to provide an update regarding our proposed merger with Alcon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As I previously shared, we scheduled the Special Meeting of stockholders to vote on the Alcon merger proposal for October&nbsp;23. Following discussions with
Alcon, we agreed to adjourn the meeting without a vote, and earlier today, we announced that we are postponing the Special Meeting to December&nbsp;3. It is not uncommon in a contested M&amp;A process for special meetings to be adjourned and
postponed to solicit votes. We agreed with Alcon to take these steps in light of ongoing discussions we are having with Alcon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Special Meeting will
now take place at 8:30&nbsp;a.m. Pacific Time on December&nbsp;3, 2025. The new record date for the Special Meeting is the close of business on October&nbsp;24, 2025. Stockholders who hold shares as of the record date will be eligible to vote at the
postponed Special Meeting on December&nbsp;3, 2025, and STAAR will be providing a notice of the meeting and other materials to such stockholders in advance of the meeting date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We recognize that there has been a lot of noise around STAAR over the last several months, and we could not be more proud of the resilience this team has
shown. You have continued to execute with a relentless commitment to our priorities and a fierce dedication to supporting the surgeons and patients around the world who rely on STAAR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nothing is changing for STAAR with today&#8217;s announcement, and our original merger timeline remains intact. Prior to the closing of the merger, we will
continue to operate business as usual. The best way for you to help is by remaining focused on your responsibilities to advance the important work underway across the Company to expand the reach of EVO ICL to provide visual freedom for those in
need. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of the STAAR Board of Directors and management team, thank you for your continued dedication to STAAR and our mission. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g87705g1008194101579.jpg" ALT="LOGO" STYLE="width:1.18403in;height:0.763194in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stephen C. Farrell </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g87705g1008194101767.jpg" ALT="LOGO" STYLE="width:2.35625in;height:0.253472in;">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Information About the Merger and Where to Find It </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication relates to the proposed transaction involving STAAR. In connection with the proposed transaction, STAAR has filed relevant materials with
the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;), including STAAR&#8217;s definitive proxy statement on Schedule 14A (the &#8220;Proxy Statement&#8221;), on September 16, 2025. The Proxy Statement was first sent to STAAR
stockholders on September 16, 2025. This communication is not a substitute for the Proxy Statement or any other document that STAAR may file with the SEC or send to its stockholders in connection with the proposed transaction. BEFORE MAKING ANY
VOTING DECISION, STOCKHOLDERS OF STAAR ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC, INCLUDING THE PROXY STATEMENT, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS THERETO, IN CONNECTION WITH THE PROPOSED TRANSACTION WHEN THEY
BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain the documents (when available) free of charge at the SEC&#8217;s website, www.sec.gov, or by
visiting STAAR&#8217;s investor relations website, https://investors.staar.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Offer or Solicitation </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication is for informational purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the
solicitation of an offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the proposed transaction or otherwise,
nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participants in the
Solicitation </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under SEC rules, STAAR and certain of its directors, executive officers and other members of management and employees may be deemed to
be participants in the solicitation of proxies from the holders of STAAR&#8217;s common stock in connection with the proposed transaction. Information about the directors and executive officers of STAAR and their ownership of STAAR&#8217;s common
stock is set forth in the Proxy Statement, the definitive proxy statement for STAAR&#8217;s 2025 Annual Meeting of Stockholders (the &#8220;Annual Proxy Statement&#8221;), which was filed with the SEC on April 24, 2025 (and which is available at
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000718937/000095017025058174/staa-0250424.htm), including the sections captioned &#8220;Compensation of Directors,&#8221; &#8220;Information Regarding Executive Officers&#8221; and &#8220;Security
Ownership of Principal Shareholders and Management,&#8221; or its Annual Report on Form 10-K for the year ended December 27, 2024, which was filed with the SEC on February 21, 2025 (and which is available at
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000718937/000095017025024813/staa-20241227.htm), and in other documents filed by STAAR with the SEC. To the extent holdings of such participants in STAAR&#8217;s securities have changed since the
amounts described in the Proxy Statement, such changes have been reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4 filed with the SEC by STAAR&#8217;s directors and executive officers.
These documents can be obtained free of charge from the sources indicated above. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise,
will be contained in other relevant materials to be filed with the SEC in respect of the proposed transaction when they become available. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information covered by this communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements often contain words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;will,&#8221;
&#8220;should,&#8221; &#8220;may,&#8221; and similar terms. All statements in this communication that are not statements of historical fact are forward-looking statements. These forward-looking statements are neither promises nor guarantees and
involve known and unknown risks, uncertainties and other important factors that may cause actual results, performance or achievements to be materially different from what is expressed or implied by the forward-looking statements, including, but not
limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Alcon merger agreement or could cause the consummation of the proposed transaction to be delayed or to fail to occur; (2) the
failure to obtain approval of the proposed transaction from STAAR&#8217;s stockholders; (3) the failure to obtain certain required regulatory approvals or the failure to satisfy any of the other closing conditions to the completion of the proposed
transaction within the expected timeframes or at all; (4) risks related to disruption of management&#8217;s attention from STAAR&#8217;s ongoing business operations due to the proposed transaction; (5) the effect of the announcement of the proposed
transaction on the ability of STAAR to retain and hire key personnel and maintain relationships with its customers, suppliers and others with whom it does business, or on its operating results and business generally; (6) the ability of STAAR to meet
expectations regarding the timing and completion of the transaction; (7) the outcome of any legal proceedings that may be instituted against STAAR related to the proposed transaction; (8) the possibility that STAAR&#8217;s stock price may decline
significantly if the proposed transaction is not consummated; and (9) other important factors set forth in the Proxy Statement under the caption &#8220;Risk Factors&#8221; and STAAR&#8217;s Annual Report on Form 10-K for the year ended December 27,
2024 under the caption &#8220;Risk Factors,&#8221; as any such factors may be updated from time to time in STAAR&#8217;s other filings with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements speak only as of the date they are made and, except as may be required under applicable law, STAAR undertakes no obligation to
update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g87705g1008194101579.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g87705g1008194101579.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !( ' # 2(  A$! Q$!_\0
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M>?EQ^9% 'KMYJ=EI\32WEU# @ZF1PM8=QX]\.PPRM%J4=U+'MQ!;_/(Y;H%
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?#I110!;HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g87705g1008194101767.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g87705g1008194101767.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  8 -\# 2(  A$! Q$!_\0
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7*W>N)=VD<801?90AX& <@UT-%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
